Further studies will be needed to explore the therapeutic potential of interventions aimed at the CXCL12/CXCR4 axis in pregnancy disorders related to immunological and angiogenic imbalances during early gestation, such as recurrent pregnancy loss and preeclampsia. The gene discussed is CXCR4; the disease is preeclampsia.